Regulatory Strategy Roadmap Toolkit
Define your regulatory pathway before you commit your resources — with templates covering strategy memos, global market entry, submission timelines, and launch readiness.
What You Get
Regulatory Strategy Memo Template
Formal regulatory strategy document for Class I, II, and III medical devices. Structured sections for device description, intended use, predicate analysis, classification determination, regulatory pathway selection, key risks and mitigations, submission timeline, and strategic recommendations. Designed for internal alignment and investor/board communication.
Product Risk and Regulatory Classification Worksheet
Structured worksheet for determining FDA device classification (Class I/II/III), identifying the applicable 21 CFR Part, assessing 510k vs PMA vs De Novo pathway, and documenting the product code and regulation number. Includes EU MDR/IVDR risk class determination and global classification comparison matrix.
Regulatory Submission Timeline Template
Master timeline template covering all pre-submission activities through clearance or approval. Includes milestones for design controls, testing, Pre-Sub meeting, submission preparation, FDA review, deficiency response, and post-clearance requirements. Built with realistic FDA review timelines and common delay buffers based on actual submission data.
Global Market Entry Regulatory Roadmap
Multi-market regulatory planning template covering FDA (US), EU MDR/IVDR, Health Canada, TGA (Australia), and PMDA (Japan) pathways. Maps each market's requirements, estimated timelines, local distributor obligations, and the sequencing logic for maximizing market access with available resources.
Regulatory Intelligence Tracker
Ongoing regulatory intelligence tracking system for monitoring FDA guidance updates, EU MDR/IVDR amendments, relevant 510k clearances, warning letters in your device category, and enforcement trends. Structured to feed directly into your regulatory strategy updates and competitive intelligence.
Go-to-Market Regulatory Readiness Checklist
Complete pre-launch regulatory readiness checklist covering FDA clearance/approval confirmation, labeling review, UDI registration, establishment registration, Medical Device Listing, import/export compliance, and post-market surveillance program activation. The last checklist before your first commercial shipment.
Why It Works
Strategy before submission
The regulatory strategy memo forces the classification and pathway decision before development commitments are made — the decision that determines everything downstream.
Global from day one
The global market entry roadmap covers five major markets with sequencing logic — so you are not rebuilding your regulatory strategy every time you add a new market.
Built for investor conversations
The regulatory strategy memo and submission timeline are structured for board and investor communication — not just internal use. Regulatory credibility is a fundraising tool.
"Most device companies treat regulatory strategy as something they figure out after they build the product. That is how you end up three years into development and $2M deep before finding out you needed a PMA. These templates force the right questions at the right time."
"The global market entry roadmap paid for itself on day one. We had been planning to pursue FDA first, then EU. The roadmap made it clear that running them in parallel was faster and cheaper given our device class. We adjusted the plan before we had committed the resources."
FAQ
When should I develop a regulatory strategy?
As early as concept phase. Regulatory pathway determines testing requirements, design control scope, timeline, and capital requirements. Late pathway changes are expensive. The earlier you document your strategy, the less you pay to change it.
Does this cover EU as well as FDA?
Yes. The product classification worksheet includes EU MDR and IVDR risk class determination. The global market entry roadmap covers EU, FDA, Health Canada, TGA, and PMDA pathways and timelines.
What format are the documents?
All documents are editable Word and Excel templates ready for direct use and customization for your specific device and market strategy.
Define your path before you commit your resources.
6 templates. Instant access. Built for medical device regulatory strategy.
For informational purposes only. Not legal or regulatory advice. Legal